Literature DB >> 12440771

Genes involved in breast cancer metastasis to bone.

E K I Sloan1, R L Anderson.   

Abstract

Metastasis to bone occurs frequently in advanced breast cancer and is accompanied by debilitating skeletal complications. Current treatments are palliative and new therapies that specifically prevent the spread of breast cancer to bone are urgently required. While our understanding of interactions between breast cancer cells and bone cells has greatly improved, we still know little about the molecular determinants that regulate specific homing of breast cancer cells to the bone. In this review, we focus on genes that have been implicated in migration and adhesion of breast cancer cells to bone, as well as genes that promote tumor cell proliferation in the bone microenvironment. In addition, the review discusses new technologies, including better animal models, that will further assist with the identification of the molecular determinants of bone metastasis and will guide the development of new therapies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12440771     DOI: 10.1007/s00018-002-8524-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  24 in total

1.  Metastasis movies, macrophages, molecules and more. Conference on Mechanisms of Invasion and Metastasis.

Authors:  Denise Montell
Journal:  EMBO Rep       Date:  2003-05       Impact factor: 8.807

Review 2.  CXCL12 signaling in the development of the nervous system.

Authors:  Divakar S Mithal; Ghazal Banisadr; Richard J Miller
Journal:  J Neuroimmune Pharmacol       Date:  2012-01-21       Impact factor: 4.147

3.  Role of neridronate on MCF-7 estrogen dependent breast cancer model of bone metastasis: a preliminary study.

Authors:  Vanessa Nicolin; Paola Narducci; Renato Bareggi
Journal:  Invest New Drugs       Date:  2009-10-02       Impact factor: 3.850

Review 4.  Molecular alterations that drive breast cancer metastasis to bone.

Authors:  Penelope D Ottewell; Liam O'Donnell; Ingunn Holen
Journal:  Bonekey Rep       Date:  2015-03-18

5.  Oncostatin m promotes mammary tumor metastasis to bone and osteolytic bone degradation.

Authors:  Celeste Bolin; Ken Tawara; Caleb Sutherland; Jeff Redshaw; Patrick Aranda; Jim Moselhy; Robin Anderson; Cheryl L Jorcyk
Journal:  Genes Cancer       Date:  2012-02

6.  Homing of cancer cells to the bone.

Authors:  Anjali Mishra; Yusuke Shiozawa; Kenneth J Pienta; Russell S Taichman
Journal:  Cancer Microenviron       Date:  2011-08-09

7.  Differential expression of matrix metalloproteinases in brain- and bone-seeking clones of metastatic MDA-MB-231 breast cancer cells.

Authors:  Andreas M Stark; Bartosz Anuszkiewicz; Rolf Mentlein; Toshiyuki Yoneda; H Maximilian Mehdorn; Janka Held-Feindt
Journal:  J Neurooncol       Date:  2006-07-19       Impact factor: 4.130

8.  Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications.

Authors:  N Cabioglu; A A Sahin; P Morandi; F Meric-Bernstam; R Islam; H Y Lin; C D Bucana; A M Gonzalez-Angulo; G N Hortobagyi; M Cristofanilli
Journal:  Ann Oncol       Date:  2009-02-23       Impact factor: 32.976

9.  High-level expression of CXCR4 in breast cancer is associated with early distant and bone metastases.

Authors:  Chin-Sheng Hung; Hou-Yu Su; Hung-Hwa Liang; Chieh-Wen Lai; Yo-Cheng Chang; Yuan-Soon Ho; Chih-Hsiung Wu; Jau-De Ho; Po-Li Wei; Yu-Jia Chang
Journal:  Tumour Biol       Date:  2013-10-08

10.  Functional proteomics approach to investigate the biological activities of cDNAs implicated in breast cancer.

Authors:  Abigail E Witt; Lisa M Hines; Nicole L Collins; Yanhui Hu; Ruwanthi N Gunawardane; Donna Moreira; Jacob Raphael; Daniel Jepson; Malvika Koundinya; Andreas Rolfs; Barbara Taron; Steven J Isakoff; Joan S Brugge; Joshua LaBaer
Journal:  J Proteome Res       Date:  2006-03       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.